1Cervical spinal cord injury:tailoring clinical trial endpoints to relfect meaningful functional improvementsINVITED REVIEW1493-1497
3Efifcacy of granulocyte-colony stimulating factor treatment in a rat model of anterior ischemic optic neuropathyINVITED REVIEW1502-1505
4Possible protective action of neurotrophic factors and natural compounds against common neurodegenerative diseasesINVITED REVIEW1506-1508
5The biochemical pathways of central nervous system neural degeneration in niacin deifciencyINVITED REVIEW1509-1513
6Effects of naringin, a lfavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brainINVITED REVIEW1514-1517
7Shifting balance from neurodegeneration to regeneration of the brain:a novel therapeutic approach to Alzheimer’s disease and related neurodegenerative conditionsPERSPECTIVES1518-1519
8Transplantation of neurotrophin-3-transfected bone marrow mesenchymal stem cells for the repair of spinal cord injur yRESEARCH AND REPORTS1520-1524
10Cutaneous sensory nerve as a substitute for auditory nerve in solving deaf-mutes’ hearing problem:an innovation in multi-channel-array skin-hearing technologyTECHNICAL UPDATES1532-1540
11T cells promote the regeneration of neural precursor cells in the hippocampus of Alzheimer’s disease miceTECHNICAL UPDATES1541-1547
12Brain structural changes and their correlation with vascular disease in type 2 diabetes mellitus patients:a voxel-based morphometric studyTECHNICAL UPDATES1548-1556
14Telemedicine and digital management in repair and regeneration after nerve injury and in nervous system diseasesLETTERS TO THE EDITOR1567-1568
